SKI Market

Indian Indices

Nifty

26,046.95 148.40
(0.57%)

Sensex

85,267.66 449.53
( 0.53%)

Bank Nifty

59,389.95 180.10
( 0.30%)

Nifty IT

38,274.75 177.75
( 0.47%)

Global Indices

Nasdaq

48,475.79 -249.23
(-0.51%)

Dow Jones

6,848.05 -73.95
(-1.07%)

Hang Seng

50,843.93 695.11
(1.39%)

Nikkei 225

9,668.36 -34.80
(-0.36%)

Forex

USD-INR

90.19 0.30
(0.34%)

EUR-INR

105.70 1.00
(0.96%)

GBP-INR

120.75 0.96
(0.80%)

JPY-INR

0.58 0.01
(0.91%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

44.97

888.1

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.2

Back

Nestle India consolidated net profit declines 17.38% in the September 2025 quarter

Oct 16,2025

Net profit of Nestle India declined 17.38% to Rs 743.17 crore in the quarter ended September 2025 as against Rs 899.49 crore during the previous quarter ended September 2024. Sales rose 10.95% to Rs 5630.23 crore in the quarter ended September 2025 as against Rs 5074.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5630.23	5074.76	11
OPM %	21.79	22.94	-
PBDT	1181.84	1138.65	4
PBT	1018.49	1017.05	0
NP	743.17	899.49	-17

26,046.95 148.40 (0.57%)

85,267.66 449.53 ( 0.53%)

59,389.95 180.10 ( 0.30%)

38,274.75 177.75 ( 0.47%)

48,475.79 -249.23 (-0.51%)

6,848.05 -73.95 (-1.07%)

50,843.93 695.11 (1.39%)

9,668.36 -34.80 (-0.36%)

90.19 0.30 (0.34%)

105.70 1.00 (0.96%)

120.75 0.96 (0.80%)

0.58 0.01 (0.91%)